Your session is about to expire
← Back to Search
Creative Arts Program for Burnout (CORAL Trial)
N/A
Waitlist Available
Led By Marc Moss, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and after 12 weeks.
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if creative activities like drawing, music, writing, or physical exercises can help reduce stress, burnout, PTSD, depression, and anxiety in critical care healthcare workers. The study also looks at whether these activities can help them feel more connected to their work and develop better coping skills while spending time with their peers.
Who is the study for?
This trial is for healthcare professionals working in hospitals at least 20 hours a week who are experiencing burnout, as indicated by specific scores on the Maslach Burnout Inventory. It's not open to those unwilling to engage in any of the creative arts interventions offered.
What is being tested?
The study is testing whether visual arts, music, dance/movement, or writing/poetry can help reduce burnout, PTSD symptoms, depression and anxiety among critical care healthcare workers. It also looks at improving work purpose connection and coping skills.
What are the potential side effects?
Since this trial involves participation in creative arts programs rather than medical or pharmaceutical interventions, traditional side effects are not expected; however participants may experience emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and after 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and after 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability/Satisfaction of Intervention as assessed by Client Satisfaction Questionnaire (CSQ-8) scores to yield a homogeneous estimate of general satisfaction.
Secondary study objectives
Change in level of Burnout as measured by Maslach Burnout Inventory.
Change in level of psychological distress as measured by Posttraumatic Diagnostic Scale (PDS).
Change in level of psychological distress as measured by the Hospital Anxiety Depression Scale (HADS).
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Group I: Writing/Poetry GroupExperimental Treatment1 Intervention
Writing/Poetry group uses writing workshops using integral elements of good writing.
Group II: Visual Arts GroupExperimental Treatment1 Intervention
Visual Arts group - sketch journals
Group III: Music GroupExperimental Treatment1 Intervention
Music group involves music-listening exercises (such as lyric analysis, patient-chosen, music for relaxation and/or visualization) and active music making.
Group IV: Dance/Movement GroupExperimental Treatment1 Intervention
Dance/Movement group - movement check-in, gentle physical warm-up, and then either a structured or improvisational movement process.
Group V: Control GroupExperimental Treatment1 Intervention
Surveys at baseline and 12 weeks later.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Music
2013
Completed Phase 3
~1810
Control
2011
Completed Phase 4
~15780
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Creative arts programs, including visual, musical, written, or physical expression, help treat burnout by facilitating emotional processing, reducing stress, and enhancing coping skills. These therapies offer a non-verbal outlet for expressing complex emotions, fostering a sense of accomplishment and purpose.
This is crucial for burnout patients as it helps them reconnect with their work's purpose, develop better coping strategies, and reduce symptoms of depression and anxiety.
Protocol for the REPAT study: role of emotional processing in art therapy for breast cancer palliative care patients.A manual-based phenomenological art therapy for individuals diagnosed with moderate to severe depression (PATd): A randomized controlled study.Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders.
Protocol for the REPAT study: role of emotional processing in art therapy for breast cancer palliative care patients.A manual-based phenomenological art therapy for individuals diagnosed with moderate to severe depression (PATd): A randomized controlled study.Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders.
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,809 Previous Clinical Trials
2,822,104 Total Patients Enrolled
National Endowment for the Arts, United StatesFED
10 Previous Clinical Trials
1,776 Total Patients Enrolled
Marc Moss, MDPrincipal InvestigatorUniversity of Colorado, Denver
7 Previous Clinical Trials
1,534 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You don't want to take part in any of the four creative arts therapies.
Research Study Groups:
This trial has the following groups:- Group 1: Writing/Poetry Group
- Group 2: Visual Arts Group
- Group 3: Music Group
- Group 4: Dance/Movement Group
- Group 5: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.